Evidence map›Paper›PMID 12970431›Full record

ArticleJournal of virology2003

Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Michael A Poles, Shady Barsoum, Wenjie Yu, Jian Yu, Patricia Sun, Jeanine Daly, Tian He, Saurabh Mehandru, Andrew Talal, Martin Markowitz and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Gut Innate Immunity and HIV Pathogenesis.Current HIV/AIDS reports · 2021
    Review
  18. Review
  19. Article
  20. What Can Gamma Delta T Cells Contribute to an HIV Cure?Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michael A PolesNew York University School of Medicine Department of Medicine, New York, New York, USA.
Shady Barsoum
Wenjie Yu
Jian Yu
Patricia Sun
Jeanine Daly
Tian He
Saurabh Mehandru
Andrew Talal
Martin Markowitz
Arlene Hurley
David Ho
Linqi Zhang
Aaron Diamond AIDS Research Center · USUniversity School · USCornell University · US

Funding

WOUND HEALING IN INDIVIDUALS OF DIFFERENT AGE AND GENETIC BACKGROUNDM01RR000102 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 1985 to 2006
$32.8M
VIRAL AND IMMUNE CONSEQUENCES OF EARLY HIV1 THERAPYU01AI041534 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI MARKOWITZ, MARTIN H · 1997 to 2006
$10.1M
CONTRIBUTION OF THE THYMUS TO SIV PATHOGENESISR01AI046964 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI ZHANG, LINQI · 2000 to 2003
$1.9M
NCRR NIH HHS M01 RR000102NCRR NIH HHS M01-RR00102NIAID NIH HHS AI-01668NIAID NIH HHS AI-41534NIAID NIH HHS AI-46964NIAID NIH HHS R01 AI046964NIAID NIH HHS U01 AI041534
6 · The paper itself

Abstract

Gammadelta T cells are primarily found in the gastrointestinal mucosa and play an important role in the first line of defense against viral, bacterial, and fungal pathogens. We sought to examine the impact of human immunodeficiency virus type 1 (HIV-1) infection on mucosal as well as peripheral blood gammadelta T-cell populations. Our results demonstrate that HIV-1 infection is associated with significant expansion of Vdelta1 and contraction of Vdelta2 cell populations in both the mucosa and peripheral blood. Such changes were observed during acute HIV-1 infection and persisted throughout the chronic phase, without apparent reversion after treatment with highly active antiretroviral therapy (HAART). Despite an increase in the expression of CCR9 and CD103 mucosal homing receptors on peripheral blood gammadelta T cells in infected individuals, mucosal and peripheral blood gammadelta T cells appeared to be distinct populations, as reflected by distinct CDR3 length polymorphisms and sequences in the two compartments. Although the underlying mechanism responsible for triggering the expansion of Vdelta1 gammadelta T cells remains unknown, HIV-1 infection appears to have a dramatic impact on gammadelta T cells, which could have important implications for HIV-1 pathogenesis.

Indexed as

Acquired Immunodeficiency SyndromeAdultAgedAged, 80 and overAntiretroviral Therapy, Highly ActiveComplementarity Determining RegionsFemaleHIV-1HumansImmunity, MucosalMaleMiddle AgedReceptors, Antigen, T-Cell, gamma-deltaReceptors, CCRReceptors, ChemokineT-LymphocytesCC chemokine receptor 9Complementarity Determining RegionsReceptors, Antigen, T-Cell, gamma-deltaReceptors, CCRReceptors, Chemokine

Identifiers

PMID12970431
PMCPMC228518
OpenAlexW2136921311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.